---
figid: PMC5868815__pone.0194612.g003
figtitle: In silico identification of microRNAs predicted to regulate N-myristoyltransferase
  and Methionine Aminopeptidase 2 functions in cancer and infectious diseases
organisms:
- NA
pmcid: PMC5868815
filename: pone.0194612.g003.jpg
figlink: /pmc/articles/PMC5868815/figure/pone.0194612.g003/
number: F3
caption: The figure illustrates ErbB signaling pathway that contain genes that are
  targeted by miRNAs which regulate NMT gene. (EGF, epidermal growth factor; TGF,
  transforming growth factor; BTC, betacellulin; HB-EGF, heparin-binding epidermal
  growth factor (EGF)-like growth factor; EREG, epiregulin; NRG1, neuregulin-1; NRG2,
  neuregulin-2; NRG3, neuregulin-3; NRG4, neuregulin-4; PLCγ, phospholipase C type
  gamma; CAMK2B, calcium/calmodulin dependent protein kinase; PRKCB, Protein kinase
  C-beta; STAT5, Signal transducer and activator of transcription 5; src, Rous sarcoma
  virus gene; CRK, C T10 regulator of a tyrosine kinase; NCL, NCK Adaptor Protein
  2; PTK2, PTK2 protein tyrosine kinase 2; ABL2, V-Abl Abelson Murine Leukemia Viral
  Oncogene Homolog 2; PAK2, P21 (RAC1) Activated Kinase 2; MAP2K4, Mitogen-Activated
  Protein Kinase Kinase 4; MAPK10, Mitogen-Activated Protein Kinase 10; SOS1, SOS
  Ras/Rac Guanine Nucleotide Exchange Factor 1; Grb2, Growth Factor Receptor Bound
  Protein 2; SHC4, Src Homology 2 Domain-Containing-Transforming Protein C4; PIK3C4,
  Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit; AKT3, KT Serine/Threonine
  Kinase 3; mTOR, Mechanistic Target Of Rapamycin Kinase; BCL2, BCL2 Associated Agonist
  Of Cell Death; GSK3B, Glycogen Synthase Kinase 3 Beta; CDKN1A, Cyclin Dependent
  Kinase Inhibitor 1A; EIF4EBP1, Eukaryotic Translation Initiation Factor 4E Binding
  Protein 1; BRAF, B-Raf Proto-Oncogene, Serine/Threonine Kinase; RPS6KB1, Ribosomal
  Protein S6 Kinase B1; KRAS, KRAS Proto-Oncogene, GTPase; JUN, Jun Proto-Oncogene,
  AP-1 Transcription Factor Subunit; ELK, ETS Transcription Factor; Myc, MYC Proto-Oncogene,
  BHLH Transcription Factor; ER, endoplasmic reticulum. DNA, deoxyribonucleic acid).
papertitle: In silico identification of microRNAs predicted to regulate N-myristoyltransferase
  and Methionine Aminopeptidase 2 functions in cancer and infectious diseases.
reftext: Ranjit Chauhan, et al. PLoS One. 2018;13(3):e0194612.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9186574
figid_alias: PMC5868815__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5868815__F3
ndex: 94342a78-dea8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5868815__pone.0194612.g003.html
  '@type': Dataset
  description: The figure illustrates ErbB signaling pathway that contain genes that
    are targeted by miRNAs which regulate NMT gene. (EGF, epidermal growth factor;
    TGF, transforming growth factor; BTC, betacellulin; HB-EGF, heparin-binding epidermal
    growth factor (EGF)-like growth factor; EREG, epiregulin; NRG1, neuregulin-1;
    NRG2, neuregulin-2; NRG3, neuregulin-3; NRG4, neuregulin-4; PLCγ, phospholipase
    C type gamma; CAMK2B, calcium/calmodulin dependent protein kinase; PRKCB, Protein
    kinase C-beta; STAT5, Signal transducer and activator of transcription 5; src,
    Rous sarcoma virus gene; CRK, C T10 regulator of a tyrosine kinase; NCL, NCK Adaptor
    Protein 2; PTK2, PTK2 protein tyrosine kinase 2; ABL2, V-Abl Abelson Murine Leukemia
    Viral Oncogene Homolog 2; PAK2, P21 (RAC1) Activated Kinase 2; MAP2K4, Mitogen-Activated
    Protein Kinase Kinase 4; MAPK10, Mitogen-Activated Protein Kinase 10; SOS1, SOS
    Ras/Rac Guanine Nucleotide Exchange Factor 1; Grb2, Growth Factor Receptor Bound
    Protein 2; SHC4, Src Homology 2 Domain-Containing-Transforming Protein C4; PIK3C4,
    Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit; AKT3, KT Serine/Threonine
    Kinase 3; mTOR, Mechanistic Target Of Rapamycin Kinase; BCL2, BCL2 Associated
    Agonist Of Cell Death; GSK3B, Glycogen Synthase Kinase 3 Beta; CDKN1A, Cyclin
    Dependent Kinase Inhibitor 1A; EIF4EBP1, Eukaryotic Translation Initiation Factor
    4E Binding Protein 1; BRAF, B-Raf Proto-Oncogene, Serine/Threonine Kinase; RPS6KB1,
    Ribosomal Protein S6 Kinase B1; KRAS, KRAS Proto-Oncogene, GTPase; JUN, Jun Proto-Oncogene,
    AP-1 Transcription Factor Subunit; ELK, ETS Transcription Factor; Myc, MYC Proto-Oncogene,
    BHLH Transcription Factor; ER, endoplasmic reticulum. DNA, deoxyribonucleic acid).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ERBB2
  - ERBB3
  - ERBB4
  - PLCG1
  - PLCG2
  - PRKCB
  - EGF
  - AR
  - SRC
  - FGR
  - FYN
  - YES1
  - PTK2
  - HBEGF
  - EREG
  - CRK
  - ABL2
  - JUN
  - JUNB
  - JUND
  - NCK2
  - MAP2K4
  - PAK2
  - PKN2
  - MAPK10
  - EPHB1
  - KCNH8
  - OGDH
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - KRAS
  - NRAS
  - MYC
  - SHC4
  - SOS1
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - GRB2
  - NRG1
  - NRG2
  - GAB1
  - PIGU
  - MTOR
  - NRG3
  - NRG4
  - BAD
  - PIK3CA
  - GSK3B
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - CDPF1
  - CBL
  - CNR1
  - BTC
  - NEU1
  - NEURL1
  - Ca2+
  - Pancreatic cancer
  - lung cancer
  - cancers
  - Glioma
---
